Oculis (OCS) SEC Filings & 10K Form

$12.02
+0.07 (+0.59%)
(As of 04/26/2024 ET)

Recent Oculis SEC Filings

DateFilerForm TypeView
04/22/2024
7:43 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
3:30 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B5
04/11/2024
3:14 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
11:15 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form EFFECT
04/02/2024
11:15 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form EFFECT
04/01/2024
5:53 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/01/2024
5:36 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form POS AM
03/19/2024
5:45 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/19/2024
5:30 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
8:06 PM
Oculis (Subject)
Oculis Holding AG (Subject)
Pivotal bioVenture Partners Fund I, L.P. (Filed by)
Form SC 13G/A
02/09/2024
5:47 AM
LSP 7 Cooperative UA (Filed by)
Oculis (Subject)
Oculis Holding AG (Subject)
Form SC 13G
11/15/2023
6:45 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B3
11/15/2023
6:03 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2023
6:53 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B3
08/29/2023
3:28 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2023
6:22 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/06/2023
4:16 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2023
3:21 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2023
3:24 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B3
06/07/2023
4:10 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B3
06/02/2023
5:07 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 424B4
06/01/2023
3:15 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
11:15 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form EFFECT
05/30/2023
5:09 AM
Oculis (Filer)
Oculis Holding AG (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
05/22/2023
7:28 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2023
11:15 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form EFFECT
05/02/2023
5:06 AM
BVCF IV, L.P. (Filed by)
Oculis (Subject)
Oculis Holding AG (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OCS) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners